Showing results (241-250 of 295) with videos related to

Sort By:
Pageof 30
Journal of the American Board of Family Medicine : JABFM|April 17, 2025
A Pilot Comparison of Clinical Data Collection Methods Using Paper, Electronic Health Record Prompt, and a Smartphone ApplicationMeagan E Stabler, John M Westfall, Donald E Nease, et al.
Bipolar Disorders|July 20, 2010
The International Society for Bipolar Disorders-Battery for Assessment of Neurocognition (ISBD-BANC)Lakshmi N Yatham, Ivan J Torres, Gin S Malhi, et al.
Human Brain Mapping|May 19, 2009
DTNBP1 is associated with imaging phenotypes in schizophreniaKatherine L Narr, Philip R Szeszko, Todd Lencz, et al.
Journal of General Internal Medicine|October 18, 2024
Patient Perceptions on the Follow-Up of Abnormal Cancer Screening Test ResultsSteven J Atlas, Katherine L Gallagher, Sydney E McGovern, et al.
Neuron|November 22, 2011
Interaction between FEZ1 and DISC1 in regulation of neuronal development and risk for schizophreniaEunchai Kang, Katherine E Burdick, Ju Young Kim, et al.
Schizophrenia Bulletin|September 27, 2015
Relationship of Cognition to Clinical Response in First-Episode Schizophrenia Spectrum DisordersJoey W Trampush, Todd Lencz, Pamela DeRosse, et al.
Bipolar Disorders|May 26, 2017
The catechol-O-methyltransferase (COMT) Val158Met genotype modulates working memory-related dorsolateral prefrontal response and performance in bipolar disorderK W Miskowiak, H L Kjaerstad, M M Støttrup, et al.
Psychiatry Research|March 13, 2024
Change in neurocognitive functioning in patients with treatment-resistant depression with serial intravenous ketamine infusions: The Bio-K multicenter trialBalwinder Singh, Sagar V Parikh, Jennifer L Vande Voort, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
N-Alkyl Sulfamates as a New Class of nsP2 Cysteine Protease Inhibitors with Broad Spectrum Antialphaviral ActivityAnirban Ghoshal, John D Sears, Mohammad Anwar Hossain, et al.
JAMA|October 10, 2023
A Multilevel Primary Care Intervention to Improve Follow-Up of Overdue Abnormal Cancer Screening Test Results: A Cluster Randomized Clinical TrialSteven J Atlas, Anna N A Tosteson, Adam Wright, et al.
Pageof 30